Evidence map›Paper›PMID 32799930›Full record

ArticleBMC research notes2020

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice.

Peng Huang, Taylor A Gentile, John W Muschamp, Lee-Yuan Liu-Chen

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Peng HuangCenter for Substance Abuse Research (CSAR) & Department of Pharmacology, Lewis Katz School of Medicine at Temple University, 3500 North Broad Street, MERB 851, Philadelphia, PA, 19140, USA.
Taylor A GentileCenter for Substance Abuse Research (CSAR) & Department of Pharmacology, Lewis Katz School of Medicine at Temple University, 3500 North Broad Street, MERB 851, Philadelphia, PA, 19140, USA.
John W MuschampCenter for Substance Abuse Research (CSAR) & Department of Pharmacology, Lewis Katz School of Medicine at Temple University, 3500 North Broad Street, MERB 851, Philadelphia, PA, 19140, USA.
Lee-Yuan Liu-ChenCenter for Substance Abuse Research (CSAR) & Department of Pharmacology, Lewis Katz School of Medicine at Temple University, 3500 North Broad Street, MERB 851, Philadelphia, PA, 19140, USA. lliuche@temple.edu.
Temple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Anjali M Rajadhyaksha · 2000 to 2026
$34.6M
Pharmacology of Kappa Opioid ReceptorR01DA041359 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LIU-CHEN, LEE-YUAN · 2017 to 2021
$2.9M
Mechanism of Action of L THP as an Alternative Therapy for Cocaine AddictionR01AT006899 · NCCIH · MCLEAN HOSPITAL · PI LEE, DAVID YUE-WEI, LIU-CHEN, LEE-YUAN · 2012 to 2016
$2.1M
Kappa opioid receptor in claustrumR21DA045274 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI LIU-CHEN, LEE-YUAN · 2018 to 2019
$436k
NCCIH NIH HHS R01 AT006899NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA041359NIDA NIH HHS R21 DA045274NIH HHS P30 DA013429NIH HHS R01AT006899NIH HHS R01DA041359
6 · The paper itself

Abstract

objectiveSelective kappa opioid receptor (KOR) agonists were shown to produce a dose-dependent depression of brain-stimulation reward (BSR) in the rat intracranial self-stimulation (ICSS) tests. However, limited studies using mice produced less conclusive results. Here the effects of U50,488H were re-examined on BSR in mice with a larger cohort of animals.

resultsForty C57BL/6J male mice were implanted with the electrodes in medial forebrain bundle. About a week after surgery, mice were subject to ICSS training. Only eighteen passed the two-phase procedures, at which point they readily spun the wheels to obtain reinforcing effect of BSR, and were used for the ICSS tests. Compared with saline (s.c.), U50,488H (2 mg/kg, s.c.) did not have effects on the BSR thresholds within 1 h post-treatment, while it decreased the maximum wheel-spinning rates in a time-dependent manner. In contrast, cocaine (5 mg/kg, s.c.) decreased the BSR thresholds time-dependently without affecting the maximum wheel-spinning rates in the same cohort of mice, demonstrating the validity of our mouse ICSS models. For comparison, U50,488H (2 mg/kg, s.c.) induced significant conditioned place aversion (CPA) in a different cohort of mice without surgeries. Thus, ICSS may not be an appropriate test for KOR agonist-induced aversion in mice.

Indexed as

Receptors, Opioid, kappaReward3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerAnimalsBrainMaleMiceMice, Inbred C57BLRats3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerReceptors, Opioid, kappaBrain-stimulation rewardConditioned place aversionICSSKappa opioid receptorU50,488H

Identifiers

PMID32799930
PMCPMC7429879
OpenAlexW3049211786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.